GlassScriptPhysician profile
Kenneth Yemisi Igbalode
NPI 1235577883
$11,887.69
in general payments reported to CMS, 2019-2025
28 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,869 · 2020: $1,375 · 2021: $391 · 2022: $708 · 2023: $1,353 · 2024: $1,660 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,358 · Food and Beverage: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,358.46 |
| Food and Beverage | $2,185.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,124.93 | 2019-2024 | Watchman Access System, Watchman Flx |
| Abbott Laboratories | $1,687.59 | 2019-2025 | Dragonfly Opstar, Optis, Mitraclip |
| Shockwave Medical, INC | $1,256.50 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,144.25 | 2019-2021 | |
| Medtronic, INC. | $950.34 | 2021-2025 | Ffrangio, Heli-Fx Endoanchor System, Symplicity G3 |
| Bard Peripheral Vascular, INC. | $929.66 | 2019 | |
| Edwards Lifesciences Corporation | $622.35 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $485.82 | 2019-2020 | |
| Terumo Medical Corporation | $447.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $344.94 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $315.39 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $261.51 | 2019-2024 | Farxiga |
| Amgen INC. | $236.87 | 2019-2020 | |
| Biotronik INC. | $212.05 | 2019-2020 | |
| Inari Medical, INC. | $200.94 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $121.78 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $118.81 | 2019-2020 | |
| Astellas Pharma US INC | $87.55 | 2019-2020 | |
| Medtronic Vascular, INC. | $87.50 | 2019 | |
| Philips North America LLC | $69.07 | 2019-2024 | (Bh4) Igt Devices Undivided |
| Chiesi USA, INC. | $33.20 | 2019 | |
| Pfizer INC. | $28.66 | 2019 | |
| Kestra Medical Technology Services, INC. | $28.12 | 2024 | Assure Wcd |
| Canon Medical Systems USA, INC. | $23.63 | 2024 | Interventional Angiography System |
| Cardinal Health 200 LLC | $22.91 | 2019 | |
| Portola Pharmaceuticals, LLC | $16.40 | 2019 | |
| Heartflow, INC. | $15.73 | 2019 | |
| Cardiovascular Systems INC. | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Igbalode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.